JRCT ID: jRCT2080220468
Registered date:20/11/2007
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 05/11/2007 |
Target sample size | 771 |
Countries of recruitment | Japan,Asia except Japan,North America,South America,Europe,Africa |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Nilotinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Imatinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy confirmatory |
---|---|
Secondary Outcome | safety efficacy pharmacokinetics |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT00471497,JapicCTI-070478 |